Impact of heart rate reduction with maximal tolerable dose of bisoprolol on left ventricular reverse remodeling

Suk Won Choi, Seongwoo Han, Wan Joo Shim, Dong Ju Choi, Yong Jin Kim, Byung Su Yoo, Kyung Kuk Hwang, Hui Kyung Jeon, Mi Seung Shin, Kyu Hyung Ryu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: We aimed to evaluate effect of heart rate (HR) reduction on left ventricular reverse remodeling (LVRR) in Korean patients with heart failure with reduced ejection fraction (HFrEF). Methods: Ambulatory patients with HFrEF, who had paired echocardiograms, N-terminal prohormone brain natriuretic peptide (NT-proBNP), and global assessment score (GAS) at baseline and 6-month (n = 157), were followed up on preset treatment schedule with bisoprolol. Results: The LVRR occurred in 49 patients (32%) at 6-month. In multivariable analysis, independent predictors associated with LVRR were use of anti-aldosterone agent (odds ratio [OR], 4.18; 95% confidence interval [CI], 1.80-9.71), young age (OR, 0.96; 95% CI, 0.92-0.99), high baseline HR (OR, 3.76; 95% CI, 1.40-10.10), and favorable baseline GAS (OR, 1.73; 95% CI, 1.06-2.81). Beneficial effect of bisoprolol, in terms of LVRR, NT-proBNP, and GAS, was remarkable in the high HR group (baseline HR = 75 beats per minute [bpm]), which showed a large HR reduction. Conclusion: High baseline HR (≥ 75 bpm) showed an association with LVRR and improvement of NT-proBNP and GAS in patients with HFrEF. This seems to be due to a large HR reduction after treatments with bisoprolol. Trial registry at www.ClinicalTrials.gov, NCT00749034.

Original languageEnglish
Article numbere171
JournalJournal of Korean medical science
Volume33
Issue number25
DOIs
Publication statusPublished - 2018 Jun 1

Fingerprint

Bisoprolol
Ventricular Remodeling
Heart Rate
Brain Natriuretic Peptide
Odds Ratio
Confidence Intervals
Heart Failure
Aldosterone
Registries
Appointments and Schedules
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Choi, Suk Won ; Han, Seongwoo ; Shim, Wan Joo ; Choi, Dong Ju ; Kim, Yong Jin ; Yoo, Byung Su ; Hwang, Kyung Kuk ; Jeon, Hui Kyung ; Shin, Mi Seung ; Ryu, Kyu Hyung. / Impact of heart rate reduction with maximal tolerable dose of bisoprolol on left ventricular reverse remodeling. In: Journal of Korean medical science. 2018 ; Vol. 33, No. 25.
@article{62f086c9d1364731ba846a582bf5926e,
title = "Impact of heart rate reduction with maximal tolerable dose of bisoprolol on left ventricular reverse remodeling",
abstract = "Background: We aimed to evaluate effect of heart rate (HR) reduction on left ventricular reverse remodeling (LVRR) in Korean patients with heart failure with reduced ejection fraction (HFrEF). Methods: Ambulatory patients with HFrEF, who had paired echocardiograms, N-terminal prohormone brain natriuretic peptide (NT-proBNP), and global assessment score (GAS) at baseline and 6-month (n = 157), were followed up on preset treatment schedule with bisoprolol. Results: The LVRR occurred in 49 patients (32{\%}) at 6-month. In multivariable analysis, independent predictors associated with LVRR were use of anti-aldosterone agent (odds ratio [OR], 4.18; 95{\%} confidence interval [CI], 1.80-9.71), young age (OR, 0.96; 95{\%} CI, 0.92-0.99), high baseline HR (OR, 3.76; 95{\%} CI, 1.40-10.10), and favorable baseline GAS (OR, 1.73; 95{\%} CI, 1.06-2.81). Beneficial effect of bisoprolol, in terms of LVRR, NT-proBNP, and GAS, was remarkable in the high HR group (baseline HR = 75 beats per minute [bpm]), which showed a large HR reduction. Conclusion: High baseline HR (≥ 75 bpm) showed an association with LVRR and improvement of NT-proBNP and GAS in patients with HFrEF. This seems to be due to a large HR reduction after treatments with bisoprolol. Trial registry at www.ClinicalTrials.gov, NCT00749034.",
author = "Choi, {Suk Won} and Seongwoo Han and Shim, {Wan Joo} and Choi, {Dong Ju} and Kim, {Yong Jin} and Yoo, {Byung Su} and Hwang, {Kyung Kuk} and Jeon, {Hui Kyung} and Shin, {Mi Seung} and Ryu, {Kyu Hyung}",
year = "2018",
month = "6",
day = "1",
doi = "10.3346/jkms.2018.33.e171",
language = "English",
volume = "33",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "25",

}

Impact of heart rate reduction with maximal tolerable dose of bisoprolol on left ventricular reverse remodeling. / Choi, Suk Won; Han, Seongwoo; Shim, Wan Joo; Choi, Dong Ju; Kim, Yong Jin; Yoo, Byung Su; Hwang, Kyung Kuk; Jeon, Hui Kyung; Shin, Mi Seung; Ryu, Kyu Hyung.

In: Journal of Korean medical science, Vol. 33, No. 25, e171, 01.06.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Impact of heart rate reduction with maximal tolerable dose of bisoprolol on left ventricular reverse remodeling

AU - Choi, Suk Won

AU - Han, Seongwoo

AU - Shim, Wan Joo

AU - Choi, Dong Ju

AU - Kim, Yong Jin

AU - Yoo, Byung Su

AU - Hwang, Kyung Kuk

AU - Jeon, Hui Kyung

AU - Shin, Mi Seung

AU - Ryu, Kyu Hyung

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Background: We aimed to evaluate effect of heart rate (HR) reduction on left ventricular reverse remodeling (LVRR) in Korean patients with heart failure with reduced ejection fraction (HFrEF). Methods: Ambulatory patients with HFrEF, who had paired echocardiograms, N-terminal prohormone brain natriuretic peptide (NT-proBNP), and global assessment score (GAS) at baseline and 6-month (n = 157), were followed up on preset treatment schedule with bisoprolol. Results: The LVRR occurred in 49 patients (32%) at 6-month. In multivariable analysis, independent predictors associated with LVRR were use of anti-aldosterone agent (odds ratio [OR], 4.18; 95% confidence interval [CI], 1.80-9.71), young age (OR, 0.96; 95% CI, 0.92-0.99), high baseline HR (OR, 3.76; 95% CI, 1.40-10.10), and favorable baseline GAS (OR, 1.73; 95% CI, 1.06-2.81). Beneficial effect of bisoprolol, in terms of LVRR, NT-proBNP, and GAS, was remarkable in the high HR group (baseline HR = 75 beats per minute [bpm]), which showed a large HR reduction. Conclusion: High baseline HR (≥ 75 bpm) showed an association with LVRR and improvement of NT-proBNP and GAS in patients with HFrEF. This seems to be due to a large HR reduction after treatments with bisoprolol. Trial registry at www.ClinicalTrials.gov, NCT00749034.

AB - Background: We aimed to evaluate effect of heart rate (HR) reduction on left ventricular reverse remodeling (LVRR) in Korean patients with heart failure with reduced ejection fraction (HFrEF). Methods: Ambulatory patients with HFrEF, who had paired echocardiograms, N-terminal prohormone brain natriuretic peptide (NT-proBNP), and global assessment score (GAS) at baseline and 6-month (n = 157), were followed up on preset treatment schedule with bisoprolol. Results: The LVRR occurred in 49 patients (32%) at 6-month. In multivariable analysis, independent predictors associated with LVRR were use of anti-aldosterone agent (odds ratio [OR], 4.18; 95% confidence interval [CI], 1.80-9.71), young age (OR, 0.96; 95% CI, 0.92-0.99), high baseline HR (OR, 3.76; 95% CI, 1.40-10.10), and favorable baseline GAS (OR, 1.73; 95% CI, 1.06-2.81). Beneficial effect of bisoprolol, in terms of LVRR, NT-proBNP, and GAS, was remarkable in the high HR group (baseline HR = 75 beats per minute [bpm]), which showed a large HR reduction. Conclusion: High baseline HR (≥ 75 bpm) showed an association with LVRR and improvement of NT-proBNP and GAS in patients with HFrEF. This seems to be due to a large HR reduction after treatments with bisoprolol. Trial registry at www.ClinicalTrials.gov, NCT00749034.

UR - http://www.scopus.com/inward/record.url?scp=85048678238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048678238&partnerID=8YFLogxK

U2 - 10.3346/jkms.2018.33.e171

DO - 10.3346/jkms.2018.33.e171

M3 - Article

C2 - 29915522

AN - SCOPUS:85048678238

VL - 33

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 25

M1 - e171

ER -